Article Information
History
- November 8, 2023.
Article Versions
- Version 1 (October 25, 2023 - 15:49).
- Version 2 (October 26, 2023 - 12:38).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kathryn Dovel1,2,§,
- Julie Hubbard1,
- Lycias Zembe3,
- Nathan Ford4,
- Morna Cornell5,
- Will Belshe1,
- Lawrence Long6,7,
- Stephanie Davis4,
- Paula A. Munderi8,
- Rachel Baggaley4 and
- Wole Ameyan4
- 1University of California, Los Angeles David Geffen School of Medicine
- 2Partners in Hope Medical Center, Lilongwe, Malawi
- 3Joint United Nations Programme on UNAIDS, Switzerland
- 4Department of HIV/AIDS, Viral Hepatis and STIs, World Health Organization, Geneva, Switzerland
- 5Centre for Infectious Disease Epidemiology & Research, School of Public Health, University of Cape Town, Cape Town, South Africa
- 6Health Economics and Epidemiology Research Office (HE²RO), Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa
- 7Department of Global Health, Boston University School of Public Health, Boston, United States
- 8Programme Innovation for Prevention Treatment & Pediatrics| UNAIDS
- ↵§Corresponding Author: Kathryn Dovel, Division of Infectious Diseases, David Geffen School of Medicine 10833 Le Conte Ave, Los Angeles, CA 90095, Phone: +13108838179, Email: kdovel{at}mednet.ucla.edu / kldovel{at}gmail.com